{"id":10959,"date":"2021-02-25T00:00:00","date_gmt":"2021-02-25T05:00:00","guid":{"rendered":"https:\/\/myeloma.ca\/1970\/01\/01\/bulletin-dinformations-3-sur-la-covid-19-et-le-myelome\/"},"modified":"2023-10-17T12:47:18","modified_gmt":"2023-10-17T17:47:18","slug":"bulletin-dinformations-3-sur-la-covid-19-et-le-myelome-2","status":"publish","type":"post","link":"https:\/\/myeloma.ca\/fr\/2021\/02\/25\/bulletin-dinformations-3-sur-la-covid-19-et-le-myelome-2\/","title":{"rendered":"BULLETIN D&rsquo;INFORMATIONS #3 SUR LA COVID-19 ET LE MY\u00c9LOME"},"content":{"rendered":"<p>My\u00e9lome Canada&nbsp;s\u2019engage \u00e0 vous fournir l\u2019information la plus fiable et la plus r\u00e9cente possible sur le coronavirus (COVID-19) et le my\u00e9lome.&nbsp;C\u2019est pourquoi nous avons cr\u00e9\u00e9 un bulletin d\u2019informations sur la COVID-19 et le my\u00e9lome.<\/p>\n<p><strong>Parmi les sujets abord\u00e9s cette semaine&nbsp;:<\/strong><\/p>\n<ul>\n<li>Essais Cliniques<br \/>\n\t&nbsp;<\/li>\n<li>Le tocilizumab am\u00e9liore consid\u00e9rablement les r\u00e9sultats cliniques des patients atteints de pneumonie COVID-19 mod\u00e9r\u00e9e ou s\u00e9v\u00e8re<br \/>\n\t&nbsp;<\/li>\n<li>SCIENCE: Le virus sournois<br \/>\n\t&nbsp;&nbsp;<\/li>\n<li>DON DE PLASMA \u2013 Un premier donneur convalescent pour aider les malades&nbsp;&nbsp;<br \/>\n\t&nbsp;<\/li>\n<li>\u200bWebinaires&nbsp;\u00ab&nbsp;COVID-19 et my\u00e9lome&nbsp;\u00bb<\/li>\n<\/ul>\n<p><a href=\"https:\/\/conta.cc\/2YglmyO\">Cliquez ici<\/a> pour en savoir plus.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>My\u00e9lome Canada&nbsp;s\u2019engage \u00e0 vous fournir l\u2019information la plus fiable et la plus r\u00e9cente possible sur le coronavirus (COVID-19) et le my\u00e9lome.&nbsp;C\u2019est pourquoi nous avons cr\u00e9\u00e9 un bulletin d\u2019informations sur la COVID-19 et le my\u00e9lome. Parmi les sujets abord\u00e9s cette semaine&nbsp;: Essais Cliniques &nbsp; Le tocilizumab am\u00e9liore consid\u00e9rablement les r\u00e9sultats cliniques des patients atteints de pneumonie [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[53,50,58],"tags":[],"class_list":["post-10959","post","type-post","status-publish","format-standard","hentry","category-actualites-et-evenement","category-news-events","category-nouvelles-de-myelome-canada"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/10959","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/comments?post=10959"}],"version-history":[{"count":1,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/10959\/revisions"}],"predecessor-version":[{"id":22113,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/10959\/revisions\/22113"}],"wp:attachment":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/media?parent=10959"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/categories?post=10959"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/tags?post=10959"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}